Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?

TURGUT, BÜLENT; ÇİFTÇİ, ESRA; ERTÜRK, SEYİT; Cetin, BÜLENT; Aker, Handan; HASBEK, ZEKİYE

doi:10.2174/1573405613666170823154759

Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?

Copy For Citation

TURGUT B., ÇİFTÇİ E., ERTÜRK S. A., Cetin B., Aker H., HASBEK Z.

CURRENT MEDICAL IMAGING REVIEWS, vol.13, no.4, pp.431-437, 2017 (SCI-Expanded)

Publication Type: Article / Article
Volume: 13 Issue: 4
Publication Date: 2017
Doi Number: 10.2174/1573405613666170823154759
Journal Name: CURRENT MEDICAL IMAGING REVIEWS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.431-437
Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Objectives: The purpose of the study is predicting the sites of the recurrence with PET/CT by serum CA-125 level and detecting the cut-off value of CA-125 for metastatic ovarian cancer (OC) in comparison with Fluorine-18 FDG PET/CT.